William Dressler
Family Medicine · Strasburg, VANPI 1912946955
Payments from drug & device makers
Across 156 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$644
- Pfizer$386
- AstraZeneca$381
- Lilly USA, LLC$303
- Amgen$247
- Boehringer Ingelheim$116
- plus $450 from 12 others
What the payments were for
- Food & beverage$2,49499%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $644 |
| Pfizer | 26 | $386 |
| AstraZeneca | 22 | $381 |
| Lilly USA, LLC | 18 | $303 |
| Amgen | 17 | $247 |
| Boehringer Ingelheim | 6 | $116 |
| Verona Pharma, Inc. | 4 | $81 |
| Johnson & Johnson | 3 | $56 |
| GSK | 3 | $46 |
| Viatris Specialty LLC | 2 | $44 |
| Mylan Specialty L.p. | 2 | $38 |
| Exact Sciences | 2 | $38 |
| Sanofi-aventis U.S. LLC | 3 | $35 |
| Dynavax Technologies Corporation | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $23 |
| GE HealthCare | 1 | $22 |
| Dompe US, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,528 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 103 | $83,509 |
| OzempicSemaglutide | 67 | $82,562 |
| JardianceEmpagliflozin | 43 | $36,816 |
| TrulicityDulaglutide | 30 | $31,435 |
| MounjaroTirzepatide | 26 | $25,805 |
| RybelsusSemaglutide | 24 | $24,068 |
| JanuviaSitagliptin Phosphate | 32 | $21,225 |
| Breo ElliptaFluticasone/Vilanterol | 47 | $18,675 |
| Spiriva HandihalerTiotropium Bromide | 12 | $17,351 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $17,326 |
| XareltoRivaroxaban | 12 | $10,262 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 73 | $9,430 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $8,315 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,097 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $6,657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $644 | $106,62991 claims |
| PfizerEliquis | $386 | $83,509103 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $303 | $57,24056 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $116 | $50,72467 claims |
| GSKBreo Ellipta, Anoro Ellipta | $46 | $24,46559 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $381 | $10,34226 claims |
| Johnson & JohnsonXarelto | $56 | $10,26212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Strasburg
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
- Samir AbdelshaheedChesapeake$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.